BELLAMY DAVIS: Open Payments
NPI 1649775412 · HOMEWOOD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 20 payments from 10 companies in 2025. Trend: 2023 $1,340 · 2024 $1,485 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| Olympus America Inc. | 3 | $193 |
| Sumitomo Pharma America, Inc. | 6 | $128 |
| Procept Biorobotics Corporation | 1 | $117 |
| UROGEN PHARMA, INC. | 2 | $47 |
| Antares Pharma, Inc. | 2 | $40 |
| Ferring Pharmaceuticals Inc. | 2 | $37 |
| Endo USA, Inc. | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Verity Pharmaceuticals Inc. | 1 | $17 |
| Janssen Biotech, Inc. | 1 | $15 |
Products named: SOLTIVE, AQUABEAM ROBOTIC SYSTEM, GEMTESA, iTIND System, ORGOVYX, JELMYTO, XYOSTED, ADSTILADRIN.
Industry payments across AL — which companies pay providers there.
